Cite this DOI

Dr. K. Deepa, Anand, D. P., & Dr. S. Kothai (2021). A Review of Investigational Treatments for Covid-19 - Zinc Supplementary. *Journal of Science & Technology*, *06*(03), 17–20. https://doi.org/10.46243/jst.2021.v6.i3.pp17-20

@article{drkdeepa2021review,
  author    = {Dr. K. Deepa and Anand, Dr. Preethi and Dr. S. Kothai},
  title     = {{A Review of Investigational Treatments for Covid-19 - Zinc Supplementary}},
  journal   = {Journal of Science \& Technology},
  year      = {2021},
  month     = {may},
  volume    = {06},
  number    = {03},
  pages     = {17--20},
  publisher = {Longman Publishers},
  issn      = {2456-5660},
  doi       = {10.46243/jst.2021.v6.i3.pp17-20},
  url       = {https://doi.org/10.46243/jst.2021.v6.i3.pp17-20},
  language  = {en},
  abstract  = {Zinc (Zn) is an investigational agent against Coronavirus disease 2019 (COVID-19) and has known protective and medicinal function for other infections. Due to the quick increase and vast number of pretentious individuals worldwide, cost-effective, globally available, and safe options with minimal side effects and simple application are extremely warranted. Zn deficiency is associated with lower survival among older patients with pneumonia and predisposes to other viral infections. Zn supplement has an efficacious against COVID-19 and to improve normal immune cell function, in particular in elderly patients. Zinc may decrease the activity of the angiotensin converting enzyme 2, the receptor for SARS-CoV-2. Zinc T-cell modulation may down regulate the cytokine storm associated with severe COVID-19. Therefore, it may be suggested that Zn supplementation may be of potential support for treatment of COVID-19}
}

TY  - JOUR
TI  - A Review of Investigational Treatments for Covid-19 - Zinc Supplementary
AU  - Dr. K. Deepa
AU  - Anand, Dr. Preethi
AU  - Dr. S. Kothai
JO  - Journal of Science & Technology
PY  - 2021
DA  - 2021/05/20/
VL  - 06
IS  - 03
SP  - 17
EP  - 20
PB  - Longman Publishers
SN  - 2456-5660
LA  - en
AB  - Zinc (Zn) is an investigational agent against Coronavirus disease 2019 (COVID-19) and has known protective and medicinal function for other infections. Due to the quick increase and vast number of pretentious individuals worldwide, cost-effective, globally available, and safe options with minimal side effects and simple application are extremely warranted. Zn deficiency is associated with lower survival among older patients with pneumonia and predisposes to other viral infections. Zn supplement has an efficacious against COVID-19 and to improve normal immune cell function, in particular in elderly patients. Zinc may decrease the activity of the angiotensin converting enzyme 2, the receptor for SARS-CoV-2. Zinc T-cell modulation may down regulate the cytokine storm associated with severe COVID-19. Therefore, it may be suggested that Zn supplementation may be of potential support for treatment of COVID-19
DO  - 10.46243/jst.2021.v6.i3.pp17-20
UR  - https://doi.org/10.46243/jst.2021.v6.i3.pp17-20
ER  -

{
    "type": "article-journal",
    "id": "10.46243/jst.2021.v6.i3.pp17-20",
    "DOI": "10.46243/jst.2021.v6.i3.pp17-20",
    "URL": "https://doi.org/10.46243/jst.2021.v6.i3.pp17-20",
    "title": "A Review of Investigational Treatments for Covid-19 - Zinc Supplementary",
    "source": "Smart Scholars DOI Registry",
    "container-title": "Journal of Science & Technology",
    "author": [
        {
            "family": "Dr. K. Deepa"
        },
        {
            "family": "Anand",
            "given": "Dr. Preethi"
        },
        {
            "family": "Dr. S. Kothai"
        }
    ],
    "issued": {
        "date-parts": [
            [
                2021,
                5,
                20
            ]
        ]
    },
    "volume": "06",
    "issue": "03",
    "page": "17-20",
    "publisher": "Longman Publishers",
    "language": "en",
    "abstract": "Zinc (Zn) is an investigational agent against Coronavirus disease 2019 (COVID-19) and has known protective and medicinal function for other infections. Due to the quick increase and vast number of pretentious individuals worldwide, cost-effective, globally available, and safe options with minimal side effects and simple application are extremely warranted. Zn deficiency is associated with lower survival among older patients with pneumonia and predisposes to other viral infections. Zn supplement has an efficacious against COVID-19 and to improve normal immune cell function, in particular in elderly patients. Zinc may decrease the activity of the angiotensin converting enzyme 2, the receptor for SARS-CoV-2. Zinc T-cell modulation may down regulate the cytokine storm associated with severe COVID-19. Therefore, it may be suggested that Zn supplementation may be of potential support for treatment of COVID-19",
    "ISSN": "2456-5660"
}

From the record as registered (version 2) — the record and its history. Programs: https://registry.smartscholars.in/api.php?action=cite&doi=10.46243%2Fjst.2021.v6.i3.pp17-20 gives all four in one JSON answer.